Bajaj HealthCare Limited (BAJAJHCARE.BO)
INR 580.45
(1.84%)
INR 580.45
(1.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.47 Billion INR | -19.41% |
| 2022 | 1.82 Billion INR | -0.65% |
| 2021 | 1.83 Billion INR | -4.68% |
| 2020 | 1.92 Billion INR | 103.38% |
| 2019 | 948.25 Million INR | 15.44% |
| 2018 | 821.42 Million INR | 405.06% |
| 2017 | 162.63 Million INR | -72.88% |
| 2016 | 599.73 Million INR | 6.59% |
| 2015 | 562.62 Million INR | 10.91% |
| 2014 | 507.3 Million INR | 25.93% |
| 2013 | 402.85 Million INR | 28.22% |
| 2012 | 314.18 Million INR | 9.01% |
| 2011 | 288.22 Million INR | -34.19% |
| 2010 | 437.95 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 472.28 Million INR | 46.28% |
| 2023 Q4 | 322.85 Million INR | -43.64% |
| 2023 Q1 | 548.07 Million INR | 30.44% |
| 2023 FY | 1.47 Billion INR | -19.41% |
| 2023 Q2 | 563.56 Million INR | 2.83% |
| 2023 Q3 | 572.81 Million INR | 1.64% |
| 2022 Q3 | 458.39 Million INR | -36.78% |
| 2022 Q4 | 420.16 Million INR | -8.34% |
| 2022 FY | 1.82 Billion INR | -0.65% |
| 2022 Q2 | 725.1 Million INR | 17.09% |
| 2022 Q1 | 619.27 Million INR | 46.95% |
| 2021 Q1 | 511.71 Million INR | 12.47% |
| 2021 Q3 | 475.96 Million INR | 10.88% |
| 2021 FY | 1.83 Billion INR | -4.68% |
| 2021 Q4 | 421.42 Million INR | -11.46% |
| 2021 Q2 | 429.25 Million INR | -16.12% |
| 2020 Q2 | 504.82 Million INR | 27.14% |
| 2020 FY | 1.92 Billion INR | 103.38% |
| 2020 Q3 | 571.72 Million INR | 13.25% |
| 2020 Q4 | 454.96 Million INR | -20.42% |
| 2020 Q1 | 397.06 Million INR | 22.08% |
| 2019 Q3 | 237.02 Million INR | 19.52% |
| 2019 Q1 | 187.67 Million INR | -0.3% |
| 2019 FY | 948.25 Million INR | 15.44% |
| 2019 Q4 | 325.23 Million INR | 37.22% |
| 2019 Q2 | 198.31 Million INR | 5.67% |
| 2018 Q1 | 424.97 Million INR | 123.1% |
| 2018 Q4 | 188.24 Million INR | -0.0% |
| 2018 FY | 821.42 Million INR | 405.06% |
| 2018 Q3 | 188.24 Million INR | -11.41% |
| 2018 Q2 | 212.48 Million INR | -50.0% |
| 2017 FY | 162.63 Million INR | -72.88% |
| 2017 Q2 | 157.35 Million INR | 0.0% |
| 2017 Q1 | 157.35 Million INR | 8.18% |
| 2017 Q4 | 190.48 Million INR | 0.0% |
| 2017 Q3 | 190.48 Million INR | 21.05% |
| 2016 Q4 | 145.45 Million INR | 0.0% |
| 2016 FY | 599.73 Million INR | 6.59% |
| 2016 Q2 | 145.39 Million INR | 0.0% |
| 2016 Q1 | 145.39 Million INR | 15.94% |
| 2016 Q3 | 145.45 Million INR | 0.04% |
| 2015 Q1 | 158.73 Million INR | 0.0% |
| 2015 Q2 | 158.73 Million INR | 0.0% |
| 2015 Q3 | 113.11 Million INR | -28.74% |
| 2015 Q4 | 125.4 Million INR | 10.87% |
| 2015 FY | 562.62 Million INR | 10.91% |
| 2014 FY | 507.3 Million INR | 25.93% |
| 2013 FY | 402.85 Million INR | 28.22% |
| 2012 FY | 314.18 Million INR | 9.01% |
| 2011 FY | 288.22 Million INR | -34.19% |
| 2010 FY | 437.95 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 94.504% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 99.049% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 88.162% |
| Granules India Limited | 16.79 Billion INR | 91.239% |
| Indoco Remedies Limited | 6.04 Billion INR | 75.638% |
| Achyut Healthcare Limited | 4.86 Million INR | -30177.844% |
| Ajanta Pharma Limited | 21.06 Billion INR | 93.013% |
| Alkem Laboratories Limited | 52.29 Billion INR | 97.186% |
| Alpa Laboratories Limited | 188.89 Million INR | -679.166% |
| Brooks Laboratories Limited | 65.62 Million INR | -2142.923% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 76.348% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 60.172% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.1% |
| Eris Lifesciences Limited | 10.42 Billion INR | 85.884% |
| FDC Limited | 8.33 Billion INR | 82.341% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 97.877% |
| Gufic Biosciences Limited | 4.16 Billion INR | 64.685% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 76.24% |
| Ipca Laboratories Limited | 29.8 Billion INR | 95.063% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -125.533% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -663.674% |
| Lasa Supergenerics Limited | 121.02 Million INR | -1116.067% |
| Laurus Labs Limited | 24.62 Billion INR | 94.022% |
| Lupin Limited | 123.71 Billion INR | 98.81% |
| Mankind Pharma Limited | 44.52 Billion INR | 96.694% |
| Medicamen Biotech Limited | 495.49 Million INR | -197.038% |
| Medico Remedies Limited | 262.14 Million INR | -461.449% |
| Megasoft Limited | 342.07 Million INR | -330.263% |
| NATCO Pharma Limited | 25.73 Billion INR | 94.281% |
| Piramal Pharma Limited | 24.47 Billion INR | 93.985% |
| RPG Life Sciences Limited | 2.48 Billion INR | 40.725% |
| Sigachi Industries Limited | 2 Billion INR | 26.494% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.431% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 64.305% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -56.177% |
| Unichem Laboratories Limited | 4.86 Billion INR | 69.747% |
| Wanbury Limited | 1.73 Billion INR | 14.956% |
| Windlas Biotech Limited | 1.33 Billion INR | -9.935% |
| ZIM Laboratories Limited | 1.26 Billion INR | -16.175% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.825% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 344.321% |
| Divi's Laboratories Limited | 32.44 Billion INR | 95.463% |
| Hester Biosciences Limited | 1.27 Billion INR | -15.558% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 74.542% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | 5.443% |
| Bal Pharma Limited | 770.19 Million INR | -91.095% |
| Strides Pharma Science Limited | 14.38 Billion INR | 89.771% |
| Venus Remedies Limited | 2.18 Billion INR | 32.566% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 74.76% |
| Nectar Lifesciences Limited | 2.97 Billion INR | 50.479% |
| Shilpa Medicare Limited | 3.54 Billion INR | 58.504% |
| Aarti Drugs Limited | 8.31 Billion INR | 82.302% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 67.87% |
| Suven Life Sciences Limited | -200.79 Million INR | 832.982% |
| Ind-Swift Limited | 2.17 Billion INR | 32.254% |
| Valiant Laboratories Limited | -60.66 Million INR | 2526.16% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 93.516% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -70.902% |
| Themis Medicare Limited | 1.5 Billion INR | 2.134% |
| Hikal Limited | 3.14 Billion INR | 53.173% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 96.852% |
| Sequent Scientific Limited | 2.97 Billion INR | 50.589% |
| Novartis India Limited | 1.32 Billion INR | -10.921% |
| Wockhardt Limited | 16.24 Billion INR | 90.937% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 92.507% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -9994.899% |
| Neuland Laboratories Limited | 8.24 Billion INR | 82.155% |
| Morepen Laboratories Limited | 6.16 Billion INR | 76.112% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -137.206% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -109.181% |